Mycelium Strategy Consulting Limited 15535626 false 2024-03-02 2025-03-31 2025-03-31 The principal activity of the company is management consultancy activities. Digita Accounts Production Advanced 6.30.9574.0 true 15535626 2024-03-02 2025-03-31 15535626 2025-03-31 15535626 core:RetainedEarningsAccumulatedLosses 2025-03-31 15535626 core:ShareCapital 2025-03-31 15535626 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 15535626 bus:SmallEntities 2024-03-02 2025-03-31 15535626 bus:AuditExemptWithAccountantsReport 2024-03-02 2025-03-31 15535626 bus:FilletedAccounts 2024-03-02 2025-03-31 15535626 bus:SmallCompaniesRegimeForAccounts 2024-03-02 2025-03-31 15535626 bus:Director1 2024-03-02 2025-03-31 15535626 bus:PrivateLimitedCompanyLtd 2024-03-02 2025-03-31 15535626 countries:AllCountries 2024-03-02 2025-03-31 iso4217:GBP xbrli:pure

Registration number: 15535626

Mycelium Strategy Consulting Limited

Unaudited Financial Statements

for the Period from 2 March 2024 to 31 March 2025

 

Mycelium Strategy Consulting Limited

(Registration number: 15535626)

Balance Sheet as at 31 March 2025

2025
£

Current assets

Cash at bank and in hand

554

Creditors: Amounts falling due within one year

(4,846)

Net liabilities

(4,292)

Capital and reserves

Called up share capital

100

Retained earnings

(4,392)

Shareholders' deficit

(4,292)

For the financial period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Director's Report and the Profit and Loss Account has been taken.

These financial statements, which have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006 and in accordance with the provisions of FRS 102 Section 1A Small Entities, were approved and authorised for issue by the director on 4 November 2025
 

.........................................

M R Spencer

Director

 

Mycelium Strategy Consulting Limited

Notes to the Unaudited Financial Statements for the Period from 2 March 2024 to 31 March 2025

1

Accounting policies

Statutory information

Mycelium Strategy Consulting Limited is a private company, limited by shares, domiciled in England and Wales, company number 15535626. The registered office is at Pegasus House, 463a Glossop Road, Sheffield, S10 2QD.

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value. The presentation currency is United Kingdom pounds sterling, which is the functional currency of the company. The financial statements are those of an individual entity.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company's activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

2

Staff numbers

The average number of persons employed by the company (including the director) during the period, was 1.

 

Mycelium Strategy Consulting Limited

Notes to the Unaudited Financial Statements for the Period from 2 March 2024 to 31 March 2025 (continued)

3

Creditors

Creditors: amounts falling due within one year

2025
£

Due within one year

Accruals and deferred income

840

Other creditors

4,006

4,846

4

Related party transactions

During the period the director, M R Spencer, had made an interest free loan account to the Company. At the balance sheet date the amount due to M R Spencer was £4,006.